TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Tillotts Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
408,255
|
435,719
|
315,943 |
Financial expenses |
4,629
|
187
|
1,778 |
Earnings before taxes |
4,364
|
10,951
|
5,211 |
EBITDA |
7,223
|
11,046
|
5,097 |
Total assets |
192,698
|
152,382
|
209,584 |
Current assets |
192,442
|
152,147
|
208,983 |
Current liabilities |
132,504
|
99,073
|
163,367 |
Equity capital |
46,012
|
40,066
|
32,564 |
- share capital |
101
|
95
|
98 |
Employees (average) |
21
|
19
|
18 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
23.9%
|
26.3%
|
15.5% |
Turnover per employee |
19,441
|
22,933
|
17,552 |
Profit as a percentage of turnover |
1.1%
|
2.5%
|
1.6% |
Return on assets (ROA) |
4.7%
|
7.3%
|
3.3% |
Current ratio |
145.2%
|
153.6%
|
127.9% |
Return on equity (ROE) |
9.5%
|
27.3%
|
16.0% |
Change turnover |
-58,381
|
129,271
|
4,567 |
Change turnover % |
-13%
|
42%
|
1% |
Chg. No. of employees |
2
|
1
|
2 |
Chg. No. of employees % |
11%
|
6%
|
13% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.